Plain-English translation of NCT07276529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This early-stage trial is testing a new surgical device called the Flexagon Self Forming Magnet Anastomosis Plus OTOLoc, which uses magnets to help surgeons reconnect healthy parts of your colon after removing a diseased section. The device is designed to make the reconnection safer and easier during minimally invasive (laparoscopic) surgery. Researchers want to see if this magnetic approach is safe and works well in real patients.
Currently, surgeons use traditional stitching or stapling techniques to reconnect the colon after surgery, which can sometimes lead to complications. This trial exists to find out if using magnets to gently hold the colon ends together while they heal might be a safer, simpler alternative.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo surgery to have a diseased portion of your colon removed and the healthy ends reconnected using the magnetic device. The surgery will be performed by experienced surgeons under general anesthesia using minimally invasive techniques. After surgery, you will have follow-up visits at discharge, day 7, day 30, and day 60 to make sure everything is healing well and the device is working as expected.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States